Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu srovnávací studie, časopisecké články
PubMed
18088403
PubMed Central
PMC2246230
DOI
10.1186/cc6202
PII: cc6202
Knihovny.cz E-zdroje
- MeSH
- antilymfocytární sérum terapeutické užití MeSH
- C-reaktivní protein metabolismus MeSH
- imunosupresiva terapeutické užití MeSH
- kalcitonin biosyntéza krev MeSH
- lidé MeSH
- peptid spojený s genem pro kalcitonin MeSH
- pooperační komplikace krev prevence a kontrola MeSH
- proteinové prekurzory biosyntéza krev MeSH
- transplantace jater * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
- Názvy látek
- antilymfocytární sérum MeSH
- C-reaktivní protein MeSH
- CALCA protein, human MeSH Prohlížeč
- imunosupresiva MeSH
- kalcitonin MeSH
- peptid spojený s genem pro kalcitonin MeSH
- proteinové prekurzory MeSH
INTRODUCTION: The aim of this study was to compare the early postoperative kinetics of procalcitonin (PCT) and C-reactive protein (CRP) serum levels in patients undergoing orthotopic liver transplantation (OLTx) with different immunosuppressive regimens. METHODS: PCT and CRP serum concentrations were measured in a group of 28 OLTx recipients before induction of anesthesia, at 4 and 8 hours following graft reperfusion, and daily until postoperative day 4. The same parameters were determined in 12 patients undergoing liver resection without conjunctive immunosuppressive therapy. Summary data are expressed as medians and ranges. Two-tailed nonparametric tests were performed and considered significant at p values of less than 0.05. RESULTS: The highest serum levels of PCT (median 3.0 ng/mL, minimum 1.4 ng/mL, maximum 13.9 ng/mL) were found in patients after OLTx without ATG therapy, on postoperative day 1. In patients with ATG administration, PCT levels were highly increased on postoperative day 1 (median 53.0 ng/mL, minimum 7.9 ng/mL, maximum 249.1 ng/mL). Thereafter, PCT values continuously decreased independently of further ATG administration in both groups of patients. No evidence of infection was present in either group. In 12 patients undergoing liver resection, peak serum PCT levels did not exceed 3.6 ng/mL. CRP serum levels in a group of patients with and without ATG therapy increased significantly on postoperative day 1, followed by a decrease. The highest levels of CRP were found in patients after liver resection on postoperative day 2 and decreased thereafter. CONCLUSION: ATG administration to patients with OLTx is associated with an increase in serum PCT levels, with peak values on postoperative day 1, and this was in the absence of any evidence of infection. The results of this study indicate that ATG immunosuppressive therapy is a stimulus for the synthesis of PCT.
Zobrazit více v PubMed
Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnosis: what is useful? Crit Care Clin. 2006;22:503–519. doi: 10.1016/j.ccc.2006.03.003. PubMed DOI
Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996–2003. doi: 10.1097/01.CCM.0000226413.54364.36. PubMed DOI
Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006;34:2596–2602. doi: 10.1097/01.CCM.0000239116.01855.61. PubMed DOI
Eberhard OK, Langefeld I, Kuse ER. Procalcitonin in the early phase after renal transplantation-will it add to diagnostic accuracy. Clin Transplant. 1998;12:206–211. PubMed
Kunz D, Pross M, König W, Lippert H, Manger T. Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc. 1998;30:2398–2399. doi: 10.1016/S0041-1345(98)00667-8. PubMed DOI
Kuse ER, Langefeld I, Jaeger K, Kulpmann WR. Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med. 2000;28:555–559. doi: 10.1097/00003246-200002000-00044. PubMed DOI
Stríz I, Jaresová M, Lácha J, Sedlácek J, Vítko S. MRP 8/14 and procalcitonin serum levels in organ transplantations. Ann Transplant. 2001;6:6–9. PubMed
Kuse ER, Jaeger K. Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease. Transpl Int. 2001;14:55. doi: 10.1111/j.1432-2277.2001.tb00011.x. PubMed DOI
Sabat R, Höflich C, Döcke WD, Oppert M, Kern F, Windrich B, Rosenberger C, Kaden J, Volk HD, Reinke P. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med. 2001;27:987–991. doi: 10.1007/s001340100949. PubMed DOI
Nylen ES, Whang KT, Snider RH, Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998;26:1001–1006. doi: 10.1097/00003246-199806000-00015. PubMed DOI
Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Müller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med. 2004;32:1715–1721. doi: 10.1097/01.CCM.0000134404.63292.71. PubMed DOI
Silomon M, Bach F, Ecker D, Graeter T, Grundmann U, Larsen R. Procalcitonin after extracorporeal circulation. Synthesis in the hepatosplanchnic region. Anaesthesist. 1999;48:395–398. doi: 10.1007/s001010050718. PubMed DOI
Meisner M, Müller V, Khakpour Z, Toegel E, Redl H. Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock. 2003;19:187–190. doi: 10.1097/00024382-200302000-00017. PubMed DOI
Redl H, Schiesser A, Tögel E, Assicot M, Bohuon C. Possible role of TNF on procalcitonin release in a baboon model of sepsis. Shock. 2001;16:25–27. PubMed
Fazakas J, Gondos T, Varga M, Sarvary E, Horovitz P, Perner F. Analysis of systemic and regional procalcitonin serum levels during liver transplantation. Transpl Int. 2003;16:465–470. doi: 10.1111/j.1432-2277.2003.tb00334.x. PubMed DOI
Redl H, Schlag G, Tögel E, Assicot M, Bohuon C. Procalcitonine release patterns in a baboon model of trauma and sepsis: relationship to cytokines and neopterin. Crit Care Med. 2000;28:3659–3663. doi: 10.1097/00003246-200011000-00021. PubMed DOI